Clinical Trial Update: A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for oral BTD-001 in adults with idiopathic hypersomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• BTD-001

Snippet

Sponsor: Balance Therapeutics | Conditions: Idiopathic Hypersomnia | Phase 2 | Status: UNKNOWN